Evidence map›Paper›PMID 42381138›Full record

ReviewEndocrine, metabolic & immune disorders drug targets2026

A Review of the Mechanisms, Biological Basis, and Active Ingredients of Traditional Chinese Medicine Formulations in Regulating Organ Function to Alleviate Osteoporosis.

Caihui Liu, Xingqin Wei, Houran Cao, Zhao Chen

Abstract readReview
In one paragraph

Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Caihui LiuThe Fifth College of Clinic Medicine, Guangzhou University of Chinese Medicine, 60 Hengfu Rd., Guangzhou, 510095, China.
Xingqin WeiThe Fifth College of Clinic Medicine, Guangzhou University of Chinese Medicine, 60 Hengfu Rd., Guangzhou, 510095, China.
Houran CaoThe Second College of Clinic Medicine, Guangzhou University of Chinese Medicine, 111 Dade Rd., Guangzhou, 510120, China.
Zhao ChenThe Fifth College of Clinic Medicine, Guangzhou University of Chinese Medicine, 60 Hengfu Rd., Guangzhou, 510095, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence and development of osteoporosis (OP) are closely related to the activity and metabolism of osteoblasts (OB) and osteoclasts (OC), which are significantly influenced by endocrine levels in the body. Traditional Chinese medicine (TCM) explains these processes through the theory of organ interconnection, suggesting that regulating the functions of the liver, spleen, and kidneys can influence hormone secretion, thereby alleviating OP symptoms. This concept forms the theoretical basis for the use of herbal medicines in OP treatment. In brief, the mechanism of action of the active components of TCM starts with their absorption through oral administration. Then, they act on metabolic organs and regulate multiple related target points, thereby influencing the synthesis and metabolic pathways of hormones and/or other endogenous substances associated with OP. Subsequently, they alter the activity of OB and OC as well as their autophagy processes. In this review, we summarize and evaluate the oral TCM used to alleviate OP, their mechanism of action, and pharmacodynamic research. We also discuss the biological associations between organ function and the effects of TCM on endocrine processes (hormones and metabolites). We evaluate the scientific validity, efficacy, advantages, and unique features of the organ- regulating treatment of OP by TCM.

Indexed as

Drugs, Chinese HerbalMedicine, Chinese TraditionalOsteoporosisAnimalsDrug CompoundingHumansOsteoblastsOsteoclastsDrugs, Chinese HerbalendocriniummechanismosteoblastsosteoclastsOsteoporosistraditional Chinese medicine

Identifiers

PMID42381138
PMCPMC13635960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.